Post-approval studies (Phase 4)Study completedNCT03035032What this trial is testingELIGARD® in Hormone-dependent Prostate Cancer PatientsWho this might be right forProstate Cancer Astellas Pharma Singapore Pte. Ltd. 107
Large-scale testing (Phase 3)Ended earlyNCT00097344What this trial is testingThe CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerWho this might be right forBreast NeoplasmsNeoplasms, Hormone-Dependent Intarcia Therapeutics 842
Testing effectiveness (Phase 2)Ended earlyNCT02420652What this trial is testingMetformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation TherapyWho this might be right forRecurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more Rutgers, The State University of New Jersey 27
Testing effectiveness (Phase 2)Study completedNCT01076335What this trial is testingNeoadjuvant Hormones + Docetaxel in Node-Positive Prostate CancerWho this might be right forProstate Cancer M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06996093What this trial is testingChemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 InhibitorWho this might be right forBreast Cancer Fudan University 2,508
Early research (Phase 1)Study completedNCT05381142What this trial is testingLearn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 YearsWho this might be right forVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot FlashesHealthy Volunteers Bayer 16
Testing effectiveness (Phase 2)Study completedNCT02441946What this trial is testingA Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerWho this might be right forBreast CancerHormone Receptor Positive TumorEarly-Stage Breast Carcinoma Eli Lilly and Company 224
Not applicableStudy completedNCT07498413What this trial is testingEpidemiology and Treatment of HR+/HER2- Breast Cancer in EnglandWho this might be right forBreast Cancer Novartis Pharmaceuticals 218,677
Post-approval studies (Phase 4)Study completedNCT02726009What this trial is testingA Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate CancerWho this might be right forProstate Cancer Ferring Pharmaceuticals 230
Testing effectiveness (Phase 2)Looking for participantsNCT05735080What this trial is testingOpen-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced CancerWho this might be right forBreast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more Incyclix Bio 150
Large-scale testing (Phase 3)Study completedNCT00004635What this trial is testingThalidomide for the Treatment of Hormone-Dependent Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 159
Large-scale testing (Phase 3)Active Not RecruitingNCT03155997What this trial is testingEndocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerWho this might be right forBreast Cancer Eli Lilly and Company 5,637
Not applicableStudy completedNCT02753686What this trial is testingTreatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted TherapyWho this might be right forHR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Novartis Pharmaceuticals 440
Not applicableStudy completedNCT01861236What this trial is testingEffectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in ArgentinaWho this might be right forAdvanced Hormone Dependent Prostate Cancer Ferring Pharmaceuticals 90
Testing effectiveness (Phase 2)Study completedNCT01220973What this trial is testingAtorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerWho this might be right forProstate Cancer Rutgers, The State University of New Jersey 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT07106632What this trial is testingOptimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic TestsWho this might be right forEarly Breast CancerPremenopausal Breast CancerHR+/HER2- Breast Cancer UNICANCER 3,380
Post-approval studies (Phase 4)UnknownNCT03111615What this trial is testingHOrmone Therapy Immediately After Histological Diagnosis of Breast CancerWho this might be right forHormone Dependent NeoplasmsBreast Cancer Female Centro Hospitalar Lisboa Ocidental 90
Testing effectiveness (Phase 2)Study completedNCT00726596What this trial is testingHydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerWho this might be right forProstate Cancer Rutgers, The State University of New Jersey 64
Early research (Phase 1)Study completedNCT04889287What this trial is testingLearn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy ParticipantsWho this might be right forVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men Bayer 16
Early research (Phase 1)Study completedNCT05351892What this trial is testingLearn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male ParticipantsWho this might be right forVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot FlashesHealthy Volunteers Bayer 18